Literature DB >> 26445089

Evaluation of the safety and efficacy of the picosecond alexandrite laser with specialized lens array for treatment of the photoaging décolletage.

Douglas C Wu1, Leysin Fletcher1, Isabella Guiha1, Mitchel P Goldman1.   

Abstract

BACKGROUND: Fractionated lasers are routinely used to treat the characteristic cutaneous signs of photoaging. In this study, we evaluate the use of picosecond pulse duration combined with a diffractive lens array for treatment of photodamage of the décolletage.
METHODS: Twenty subjects with Fitzpatrick skin types I-IV were enrolled in a prospective open-label trial evaluating the efficacy of the 755 nm picosecond pulsed alexandrite laser with diffractive lens array for treatment of photodamage to the décolletage. Each subject received a series of four laser treatments at 3 week intervals. Follow up evaluation was performed 1 and 3 months later by a masked investigator and consisted of assessment of dyspigmentation, erythema, keratosis, texture, and rhytides on a standardized 5 point scale; global aesthetic improvement 5 point scale; and investigator and subject satisfaction questionnaire. Adverse events and treatment discomfort was also assessed.
RESULTS: Statistically significant improvement in dyspigmentation, keratosis, and skin texture were observed at both 1 and 3 month follow up intervals (P < 0.05). rhytides initially demonstrated significant improvement at the 1 month time point, but this significance was not maintained at 3 months (P = 0.08). There was no statistically significant improvement noted in erythema. The majority of subjects were satisfied, with a mean rating of 2.8/6 (one being extremely satisfied and six being extremely dissatisfied). Subject pain was 3.6/10.
CONCLUSION: The 755 nm picosecond pulsed alexandrite laser with diffractive lens array can be an effective option for rejuvenation of the photodamaged décolletage.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  alexandrite; chest; fractionated; non-ablative; photodamge; picosecond; rejuvenation

Mesh:

Year:  2015        PMID: 26445089     DOI: 10.1002/lsm.22427

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  8 in total

1.  Applications of picosecond lasers beyond tattoos: pigment reduction and tissue remodeling.

Authors:  Emily Forbat; Faisal R Ali; Firas Al-Niaimi
Journal:  Lasers Med Sci       Date:  2017-02-09       Impact factor: 3.161

2.  A Prospective Double-blind, Placebo-controlled Clinical Trial Evaluating the Efficacy of a Novel Combination of Hyaluronic Acid Serum and Antioxidant Cream for Rejuvenation of the Aging Neck.

Authors:  Monica Boen; Marwan Alhaddad; Douglas C Wu; Mitchel P Goldman
Journal:  J Clin Aesthet Dermatol       Date:  2020-11-01

3.  Picosecond 532-nm neodymium-doped yttrium aluminium garnet laser-a novel and promising modality for the treatment of café-au-lait macules.

Authors:  Ofir Artzi; Joseph N Mehrabi; Amir Koren; Roni Niv; Moshe Lapidoth; Assi Levi
Journal:  Lasers Med Sci       Date:  2017-11-02       Impact factor: 3.161

4.  Histological investigation of picosecond laser-toning and fractional laser therapy.

Authors:  Shunji Nakano
Journal:  Laser Ther       Date:  2020-07-17

5.  Using normal and high pulse coverage with picosecond laser treatment of wrinkles and acne scarring: Long term clinical observations.

Authors:  Christine Dierickx
Journal:  Lasers Surg Med       Date:  2017-11-15       Impact factor: 4.025

6.  Efficient Picosecond Laser for Tattoo Removal in Rat Models.

Authors:  Yan Qu; Lei Wang; Pingyu Zhou; Wei Zhang
Journal:  Med Sci Monit       Date:  2020-07-25

7.  The Picosecond Laser Effects on Tattoo Removal and Metabolic Pathways.

Authors:  Yan Qu; Xien Feng; Jin'ning Liang; Junru Liu; Dong Gao
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-09-24

8.  Efficacy and Safety of Treatment with Fractional 1,064-nm Picosecond Laser with Diffractive Optic Element for Wrinkles and Acne Scars: A Clinical Study.

Authors:  Chung Hyeok Lee; Eun Mi Jin; Hee Seok Seo; Tae-Ui Ryu; Seung Phil Hong
Journal:  Ann Dermatol       Date:  2021-05-04       Impact factor: 1.444

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.